These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25760217)

  • 1. Granulocyte colony-stimulating factor and bone marrow mononuclear cells for stroke treatment in the aged brain.
    Buga AM; Scheibe J; Moller K; Ciobanu O; Posel C; Boltze J; Popa-Wagner A
    Curr Neurovasc Res; 2015; 12(2):155-62. PubMed ID: 25760217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow cell transplantation time-dependently abolishes efficacy of granulocyte colony-stimulating factor after stroke in hypertensive rats.
    Pösel C; Scheibe J; Kranz A; Bothe V; Quente E; Fröhlich W; Lange F; Schäbitz WR; Minnerup J; Boltze J; Wagner DC
    Stroke; 2014 Aug; 45(8):2431-7. PubMed ID: 24984745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal Approaches for Regenerative Stroke Therapies: Combination of Granulocyte Colony-Stimulating Factor with Bone Marrow Mesenchymal Stem Cells is Not Superior to G-CSF Alone.
    Balseanu AT; Buga AM; Catalin B; Wagner DC; Boltze J; Zagrean AM; Reymann K; Schaebitz W; Popa-Wagner A
    Front Aging Neurosci; 2014; 6():130. PubMed ID: 25002846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of granulocyte-colony-stimulating factor administration following autologous intramuscular implantation of bone marrow mononuclear cells: a randomized controlled trial in patients with advanced lower limb ischemia.
    Zafarghandi MR; Ravari H; Aghdami N; Namiri M; Moazzami K; Taghiabadi E; Fazel A; Pournasr B; Farrokhi A; Sharifian RA; Salimi J; Moini M; Baharvand H
    Cytotherapy; 2010 Oct; 12(6):783-91. PubMed ID: 20078390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte colony-stimulating factor improves the efficacy of autologous bone marrow-derived mononuclear cell transplantation treatment for lower limb ischemia.
    Gu Y; Guo L; Guo J; Dardik A; Zhang S; Tong Z; Zhang J; Wang Z
    Int Angiol; 2017 Aug; 36(4):346-353. PubMed ID: 27958690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies to improve post-stroke behavioral recovery in aged subjects.
    Buga AM; Bălşeanu A; Popa-Wagner A; Mogoantă L
    Rom J Morphol Embryol; 2009; 50(4):559-82. PubMed ID: 19942950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte colony-stimulating factor (G-CSF) treatment in combination with transplantation of bone marrow cells is not superior to G-CSF treatment alone after cortical stroke in spontaneously hypertensive rats.
    Diederich K; Schmidt A; Beuker C; Strecker JK; Wagner DC; Boltze J; Schäbitz WR; Minnerup J
    Front Cell Neurosci; 2014; 8():411. PubMed ID: 25538562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell therapies in preclinical models of stroke. Is the aged brain microenvironment refractory to cell therapy?
    Sandu RE; Balseanu AT; Bogdan C; Slevin M; Petcu E; Popa-Wagner A
    Exp Gerontol; 2017 Aug; 94():73-77. PubMed ID: 28093317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining Growth Factor and Bone Marrow Cell Therapy Induces Bleeding and Alters Immune Response After Stroke in Mice.
    Strecker JK; Olk J; Hoppen M; Gess B; Diederich K; Schmidt A; Schäbitz WR; Schilling M; Minnerup J
    Stroke; 2016 Mar; 47(3):852-62. PubMed ID: 26839353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II Trial of Intravenous Low-Dose Granulocyte Colony-Stimulating Factor in Acute Ischemic Stroke.
    Mizuma A; Yamashita T; Kono S; Nakayama T; Baba Y; Itoh S; Asakura K; Niimi Y; Asahi T; Kanemaru K; Mutoh T; Kuroda S; Kinouchi H; Abe K; Takizawa S
    J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1451-7. PubMed ID: 27017282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-colony stimulating factor in combination with stem cell factor confers greater neuroprotection after hypoxic-ischemic brain damage in the neonatal rats than a solitary treatment.
    Doycheva D; Shih G; Chen H; Applegate R; Zhang JH; Tang J
    Transl Stroke Res; 2013 Apr; 4(2):171-8. PubMed ID: 23565130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extension of Tissue Plasminogen Activator Treatment Window by Granulocyte-Colony Stimulating Factor in a Thromboembolic Rat Model of Stroke.
    Dela Peña IC; Yang S; Shen G; Fang Liang H; Solak S; Borlongan CV
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of autologous bone marrow mononuclear cells transplantation and mobilization by granulocyte colony-stimulating factor in experimental spinal injury.
    Guo X; Bu X; Li Z; Yan Z; Jiang J; Zhou Z
    Int J Neurosci; 2012 Dec; 122(12):723-33. PubMed ID: 22862301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful regeneration after experimental stroke by granulocyte-colony stimulating factor is not further enhanced by constraint-induced movement therapy either in concurrent or in sequential combination therapy.
    Diederich K; Quennet V; Bauer H; Müller HD; Wersching H; Schäbitz WR; Minnerup J; Sommer C
    Stroke; 2012 Jan; 43(1):185-92. PubMed ID: 22020031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of bone marrow stromal cell transplantation with mobilization by granulocyte-colony stimulating factor promotes functional recovery after spinal cord transection.
    Luo J; Zhang HT; Jiang XD; Xue S; Ke YQ
    Acta Neurochir (Wien); 2009 Nov; 151(11):1483-92. PubMed ID: 19499175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid enhances the effect of bone marrow-derived mononuclear cells in a rat ischemic stroke model.
    Suda S; Katsura KI; Saito M; Kamiya N; Katayama Y
    Brain Res; 2014 May; 1565():74-81. PubMed ID: 24746498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two versus three day upfront use of granulocyte-colony stimulating factor in healthy bone marrow donors for pediatric bone marrow transplantation.
    Aksu T; Ok Bozkaya İ; Akpınar Tekgündüz S; Olcar Kanbur M; Köksal Y; Özgüner M; Özbek NY
    Transfus Apher Sci; 2017 Dec; 56(6):829-831. PubMed ID: 29153311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of ageing on biological features of bone marrow stromal cells (BMSC) in cell transplantation therapy for CNS disorders: functional enhancement by granulocyte-colony stimulating factor (G-CSF).
    Chiba Y; Kuroda S; Osanai T; Shichinohe H; Houkin K; Iwasaki Y
    Neuropathology; 2012 Apr; 32(2):139-48. PubMed ID: 21981141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial.
    Moniche F; Gonzalez A; Gonzalez-Marcos JR; Carmona M; Piñero P; Espigado I; Garcia-Solis D; Cayuela A; Montaner J; Boada C; Rosell A; Jimenez MD; Mayol A; Gil-Peralta A
    Stroke; 2012 Aug; 43(8):2242-4. PubMed ID: 22764211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte-colony-stimulating factor mobilizes bone marrow stem cells in patients with subacute ischemic stroke: the Stem cell Trial of recovery EnhanceMent after Stroke (STEMS) pilot randomized, controlled trial (ISRCTN 16784092).
    Sprigg N; Bath PM; Zhao L; Willmot MR; Gray LJ; Walker MF; Dennis MS; Russell N
    Stroke; 2006 Dec; 37(12):2979-83. PubMed ID: 17082474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.